Pura Vida Investments, LLC: investment adviser

The Adviser generally has broad and flexible investment authority with respect to each Client’s investment portfolio and provides investment advisory services based on each Client’s specific investment objectives and strategies. The Adviser does not tailor its advisory services to the individual needs of investors in the Pura Vida Funds. Each Client may institute portfolio, trading, or other restrictions, as set forth in each investment advisory agreement, private placement memorandum, operating and subscription agreements and/or other constituent documents (collectively, the “Governing Documents”). As of December 31, 2025, the Adviser had approximately $91.5 million in client regulatory assets under management, all of which were managed on a discretionary basis.

In addition, the Clients are subject to carried interest or incentive allocation (collectively, the “Performance Fee”) as set forth in each Client’s Governing Documents and is equal to a specified percentage of all income, gains, and losses derived from portfolio investments. Either the Adviser or the general partner of the Pura Vida Funds (and/or a designee thereof) is paid or allocated the Performance Fee. In addition, the Clients may be subject to other expenses, such as legal, administration, accounting, auditing, insurance, proxy voting services and other professional expenses, investment expenses such as commissions, lobbying, research fees and expenses (including research-related travel); interest on margin accounts and other indebtedness; borrowing charges on securities sold short; custodial fees, bank service fees and other expenses related to the purchase, sale or transmittal of Client assets (including designated investments). It is important that each investor who is considering an investment in a Client review the Governing Documents applicable to that Client for a detailed description of the fees and expenses applicable to such investment. Investors should review carefully Item 12, which discusses conflicts of interest related to brokerage practices. The Adviser, in its sole discretion, may waive or reduce the Management Fee and/or the Performance Fee for investors including those that are members, employees or affiliates of the Adviser, relatives of such persons, and/or for certain strategic investors.

Notwithstanding the foregoing, the Adviser reviews allocations among accounts to ensure that it does not favor accounts that pay greater Performance Fees.

It is designed only for sophisticated persons who can bear the risk of the loss of their entire investment and who have a limited need for liquidity. The Adviser can give no assurance that its investment strategy will achieve its investment objective. Prospective investors should speak with their legal, tax, and financial advisors prior to making an investment in a Pura Vida Fund. The following summary identifies the material risks related to the Adviser’s investment strategy and should be carefully evaluated before making an investment with the Adviser. The following does not intend to identify all possible risks and conflicts of interest associated with an investment with the Adviser or provide a full description of the identified risks. All investors and potential investors must review each Client’s Governing Documents carefully before deciding to invest or maintain an investment with the Adviser. Nature of Investments. The Adviser has broad discretion in making investments for Clients. Investments will generally consist of equity and debt securities, as well as derivative securities, and other assets that may be affected by business, financial market, or legal uncertainties. There can be no assurance that the Adviser will correctly evaluate the nature and magnitude of the various factors that could affect the value of and return on investments. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of a Client’s activities and the value of its investments.

Lack of Diversification. The portfolios of certain Clients may consist of a limited number of investment positions and therefore may not be diverse. In fact, the portfolios of certain Clients may consist of as few as one investment. As a result, the investment portfolio of such Clients is subject to more rapid changes in value than would be the case if the Client were required to maintain diversification among issuers, industries, geographic areas, capitalizations and/or types of securities. Healthcare Companies. Healthcare companies, including but not limited to cannabis companies, are generally subject to greater governmental regulation than other industries. Changes in governmental policies may have a material effect on the demand for or costs of certain products and services. A healthcare company must receive government approval before introducing new drugs and medical devices or procedures. This process may delay the introduction of these products and services, resulting in increased development costs, delayed cost-recovery and loss of competitive advantage, adversely affecting the company’s revenues and profitability. Expansion of facilities by healthcare providers is subject to “determinations of need” by the appropriate government authorities. This process increases the time and cost involved in these expansions, and also makes expansion plans uncertain, limiting the revenue and profitability growth potential of healthcare facilities operators and negatively affecting the price of their securities. Certain healthcare companies depend on the exclusive rights or patents for the products they develop and distribute. Patents have a limited duration and, upon expiration, other companies may market substantially similar “generic” products which cost less to develop and may cause the original developer of the product to lose market share and/or reduce the price charged for the product, resulting in lower profits for the original developer. Finally, because the products and services of healthcare companies affect the health and well-being of many individuals, these companies are especially susceptible to product liability lawsuits. The share price of a healthcare company can drop dramatically not only as a reaction to an adverse judicial ruling, but also from the adverse publicity accompanying threatened litigation. Equity Related Instruments. The Adviser intends to use equity-related instruments in its investment program. Certain options and other equity-related instruments may be subject to various types of risks, including market risk, liquidity risk, counterparty credit risk, legal risk, and operation risk. In addition, equity-related instruments can involve significant economic leverage and may, in some cases, involve significant risks of loss. Leverage. The Clients may generally utilize leverage. The use of leverage results in a Client controlling substantially more assets than the Client has equity. The use of leverage exposes a Client to additional levels of risk, including (i) greater losses from investments than would otherwise have been the case had the Client not borrowed to make the investments, (ii) margin calls or interim margin requirements which may force premature liquidations of investment positions, and (iii) losses on investments where the investment fails to earn a return that equals or exceeds the Client’s cost of borrowing such funds. In the event of a sudden, precipitous drop in value of the Client’s assets, the Client might not be able to liquidate assets quickly enough to repay its borrowings, further magnifying its losses. The Adviser may not be able to obtain leverage for a Client and therefore the Client may not be able to implement its strategy. In addition, any leverage obtained, if terminated on short notice by the lender, could force the Adviser to unwind positions quickly at prices below fair value. Short Sales. Short sales may substantially increase the impact of adverse price movements on a Client’s portfolio. A short sale involves the risk of a theoretically unlimited increase in the market price of the particular investment sold short, which could result in an inability to cover the short position. Also, securities necessary to cover a short position may not be available for purchase. High Growth Industry Risks. The Clients may have significant investments in high growth companies (e.g., healthcare and cannabis). These investments may be very volatile. In addition, these companies may face undeveloped or limited markets, have limited products, have no proven profit-making history, may operate

at a loss or with substantial variations in operating results from period to period, have limited access to capital and/or be in the developmental stages of their businesses, may be materially impacted by regulatory developments and/or approvals, have limited ability to protect their rights to certain patents, copyrights, trademarks and other trade secrets, or be otherwise adversely affected by the extremely competitive markets in which many of their competitors operate. Investor Activism. A Client may occasionally take an activist position in an attempt to influence the future direction of target companies. If a Client takes such a position, there exists the risk that the intended strategy for a particular company will be unsuccessful. Further, when securities are purchased in anticipation of influencing the future direction of a company, a substantial period of time may elapse between the Client’s purchase of the securities and the anticipated results. During this period, a portion of the Client’s capital would be committed to the securities purchased, and the Client typically might finance some portion of such purchases with borrowed funds on which it must pay interest. Additionally, if the anticipated results do not in fact occur, the Client may be required to sell its investment at a loss. Moreover, there may be instances where the Client will be restricted in transacting in or redeeming a particular investment as a result of its activist investment strategy. Because there is substantial uncertainty concerning the outcome of transactions involving the target companies in which the Client may invest, there exists a potential risk of loss by the Client of its entire investment in such companies. The Adviser may also attempt to build strong relationships with company management. In certain cases, such attempts to influence a company’s management may result in an affiliate or member of the Adviser taking a seat on the company’s board of directors. In such a case, there exists the risk that the Client will be restricted in transacting in or redeeming its investment in that company as a result of, among other things, legal restrictions on transactions by company directors or affiliates. Because there is substantial uncertainty concerning the outcome of transactions involving the target companies in which a Client may invest, there exists a potential risk of loss by the Client of its entire investment in such companies. Control Positions. To the extent that a Client owns a controlling stake in or is deemed an affiliate of a particular company, it may be subject to certain securities laws restrictions which could affect both the liquidity of the Client’s interest and the Client’s ability to liquidate its interest without adversely impacting the stock price, including insider trading restrictions and the affiliate sale restrictions of Rule 144 of the U.S. Securities Act of 1933. In addition, to the extent that affiliates of a Client or the Adviser are subject to such restrictions, the Client, by virtue of its affiliation with such entities, may be similarly restricted, regardless of whether the Client stands to benefit from such affiliate's stock ownership. If a Client, alone or as part of a group acting together for certain purposes, becomes the beneficial owner of more than 10% of certain classes of securities of a U.S. public company or places a director on the board of directors of such a company, the Client may be subject to certain additional reporting requirements and to liability for short-swing profits under Section 16 of the Exchange Act. Furthermore, the Client may also be subject to similar reporting requirements in non-U.S. jurisdictions where it holds significant positions in the securities of public companies in such jurisdictions. Lending Risks. To the extent that a Client engages in active lending transactions, it will be subject to risks associated with possible default by the borrower, insufficient collateral and legal and other costs incurred in collecting on a defaulted loan. In addition, active lending by a Client may subject it to additional regulation, as well as possible adverse tax consequences to the Client and/or its investors. Small Capitalization Companies. A Client may invest a portion of its assets in the stocks of companies with market capitalizations less than $500 million. While the Adviser believes such investments may provide significant potential for appreciation, such smaller-capitalization stocks involve a greater degree of volatility and risk than stocks of larger companies.

Debt Securities. A Client may invest in unrated or low-grade debt securities which are subject to greater risk of loss of principal and interest than higher-rated debt securities. A Client may invest in debt securities which rank junior to other outstanding securities and obligations of the issuer, all or a significant portion of which may be secured on substantially all of that issuer’s assets. A Client may invest in debt securities which are not protected by financial covenants or limitations on additional indebtedness. In addition, evaluating credit risk for foreign debt securities involves greater uncertainty because credit rating agencies throughout the world have different standards, making comparison across countries difficult. Non-U.S. Securities. To the extent a Client invests in securities of non-U.S. governments and companies that are generally denominated in non-U.S. currencies, or utilizes options on non-U.S. securities, there are certain considerations comprising both risks and opportunities not typically associated with investing in securities of the United States Government or United States companies. These considerations include changes in exchange rates and exchange control regulations, political and social instability, potential expropriation, imposition of foreign taxes, less liquid markets, less available information than is generally the case in the United States, higher transaction costs, any foreign government restrictions, greater risks associated with counterparties and settlement, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards, greater price volatility, and/or less government supervision of exchanges, brokers and issuers. Currency Risks. To the extent a Client’s investments are denominated in a foreign currency, such investments are subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for capital appreciation, and political developments. The Client may attempt to hedge such risks. Derivatives, Counterparty and Settlement Risks. To the extent a Client invests in swaps, derivative or synthetic instruments, repurchase agreements, or other over-the-counter transactions or, in certain circumstances, non-U.S. securities, the Client may take a credit risk with regard to parties with whom it trades and may also bear the risk of settlement default. These risks may differ materially from those entailed in exchange-traded transactions that generally are backed by clearing organization guarantees, daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. Transactions entered directly between two counterparties generally do not benefit from such protections and expose the parties to the risk of counterparty default. It is expected that all securities and other assets deposited with custodians or brokers will be clearly identified as being assets (directly or indirectly) of the Client, and hence the Client should not be exposed to a credit risk with regard to such parties. However, it may not always be possible to achieve this segregation, and there may be practical, or time problems associated with enforcing rights to its assets in the case of an insolvency of any such party. Many emerging market countries have different clearance and settlement procedures from developed countries. There may be no central clearing mechanism of settling trades and no central depository or custodian for the safe keeping of securities. The registration, record-keeping and transfer of instruments may be carried out manually, which may cause delays in the recording of ownership. Increased settlement risk may increase counterparty and other risk. Certain markets have experienced periods when settlement dates are extended, and during the interim, the market value of an instrument may change. Moreover, certain markets have experienced periods when settlements did not keep pace with the volume of transactions resulting in settlement difficulties. Because of the lack of standardized settlement procedures, settlement risk in emerging markets is more prominent than in more mature markets. Special Situations. A Client may invest in companies involved in (or the target of) acquisition attempts or tender offers or in companies involved in or undergoing work-outs, liquidations, spin-offs, reorganizations,

bankruptcies, or other catalytic changes or similar transactions. In any investment opportunity involving any such type of special situation, there exists the risk that the contemplated transaction either will be unsuccessful, will take considerable time or will result in a distribution of cash or a new security the value of which will be less than the purchase price to the Client of the security or other financial instrument in respect of which such distribution is received. Similarly, if an anticipated transaction does not in fact occur, the Client may be required to sell its investment at a loss. Because there is substantial uncertainty concerning the outcome of transactions involving financially troubled companies in which the Client may invest, there is a potential risk of loss by the Client of its entire investment in such companies. Convergence Risk. A Client may pursue relative value strategies by taking long positions in securities believed to be undervalued and short positions in securities believed to be overvalued. In the event that the perceived mispricing underlying the Client’s trading positions were to fail to converge toward, or were to diverge further from, the Adviser’s expectations, the Client may incur a loss. Interest Rate Risk. Generally, the value of fixed income securities will change inversely with changes in interest rates. As interest rates rise, the market value of fixed income securities tends to decrease. Conversely, as interest rates fall, the market value of fixed income securities tends to increase. This risk will be greater for long-term securities than for short-term securities. The Adviser may attempt to minimize the exposure of the portfolios to interest rate changes through the use of interest rate swaps, interest rate futures and/or interest rate options. However, there can be no guarantee that the Adviser will be successful in fully mitigating the impact of interest rate changes. Options. The purchase or sale of an option involves the payment or receipt of a premium by the investor and the corresponding right or obligation, as the case may be, to either purchase or sell the underlying security, commodity or other instrument for a specific price at a certain time or during a certain period. Purchasing options involves the risk that the underlying instrument will not change price in the manner expected, so that the investor loses its premium. Selling options involves potentially greater risk because the investor is exposed to the extent of the actual price movement in the underlying security rather than only the premium payment received (which could result in a potentially unlimited loss). Over-the-counter options also involve counterparty solvency risk. Lack of Liquidity of Client Investments. Client assets may, at any given time, include securities and other financial instruments or obligations that are thinly traded or for which no market exists and/or which are restricted as to their transferability under applicable securities laws. The sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to accurately value any such investments. Incentive Allocation. The allocation of a percentage of a Client’s net profits to the Adviser or its general partner from the investors may create an incentive for the Adviser to cause the Client to make investments that are riskier or more speculative than would be the case if this allocation were not made. Since the allocation is calculated on a basis that includes unrealized appreciation of assets, such allocation may be greater than if it were based solely on realized gains. Substantial Withdrawals. In the event that there are substantial withdrawals from a Client, it may be more difficult for the Client to generate returns since it will be operating on a smaller asset base. The Client will be responsible for fees and expenses regardless of its size or profitability. Also, if there are substantial withdrawals within a limited period of time, it may be difficult for the Client to provide sufficient funds to meet such withdrawals without liquidating positions prematurely at an inappropriate time or on unfavorable terms.

Side Letters. The Pura Vida Funds may enter into agreements with certain prospective or existing investors (“side letters”) whereby such investors may be subject to terms and conditions that are more advantageous than those set forth in the Pura Vida Fund’s Governing Documents. For example, such terms and conditions may provide for special rights to make future investments in a Pura Vida Fund or other investment vehicle, higher percentage of the investor’s capital contribution allocated to certain investments, special withdrawal rights relating to frequency and/or notice, a reduction or rebate in fees or withdrawal charges to be paid by the investor, rights to receive reports from a Pura Vida Fund on a more frequent basis and/or receive information that is not part of the standard reporting provided to other investors, and any other rights as may be negotiated by any Pura Vida Fund and such investor(s). Reliance on Efrem Kamen. The success of the Clients is significantly dependent upon the expertise and efforts of Efrem Kamen. While the Adviser has other employees, there could be adverse consequences to the Clients in the event that Efrem Kamen ceased to be available. Disclosure of Positions. The Adviser, in its sole discretion, may permit a Pura Vida Fund to disclose some or all of its positions on a select basis to certain investors if it determines that there are sufficient confidentiality agreements and procedures in place. Potential Conflicts of Interest. The Adviser may serve as the investment manager for multiple Clients, each of which may utilize substantially the same investment strategy. The Adviser will use its best efforts in connection with the purposes and objectives of each and will devote so much of its time and effort to the affairs of each as may, in its judgment, be necessary to accomplish the purposes of each. Pursuant to the terms of the relevant Governing Documents, the Adviser, and certain related parties such as the Fund’s general partner, directors, members, partners, shareholders, officers, employees, agents and affiliates (hereinafter referred to as the “Affiliated Parties”) may conduct any other business, including any business within the securities industry, whether or not such business is in competition with a particular Fund or separately managed account. Without limiting the generality of the foregoing, the Adviser and the Affiliated Parties may act as general partner, investment adviser or investment manager for others, may manage funds, separate accounts or capital for others, may have, make and maintain investments in their own name or through other entities and may serve as an officer, director, consultant, partner or stockholder of one or more investment funds, partnerships, securities firms or advisory firms. Such other entities or accounts may have investment objectives or may implement investment strategies similar or different to those of a particular Client. In addition, the Adviser and the Affiliated Parties may, through other investments, including other investment funds, have interests in the securities in which a Client invests as well as interests in investments in which a Client does not invest. The Adviser and the Affiliated Parties may give advice or take action with respect to such other entities or accounts that differs from the advice given with respect to a particular Fund. To the extent a particular investment is suitable for multiple Funds or separately managed accounts, such investments will be allocated pro rata based on assets under management or in some other manner that the Adviser and the Affiliated Parties determine is fair and equitable under the circumstances to all. Additionally, the Adviser intends to build and maintain strong relationships with the management teams of companies. To maintain its competitive edge, the Adviser plans to utilize its established relationships with the management teams of such companies. Such relationships may lead to offers to join the boards of, and provide consulting services or other services (the “Services”) to, certain companies, including, but not limited to, companies that are held in the Clients’ portfolios (“Portfolio Companies”). It is contemplated that, in certain of these arrangements, the Adviser, its affiliates or certain of its principals or employees, may receive compensation for providing such Services. The primary purpose of providing Services to Portfolio Companies would be to aid the management of such companies in their efforts to make business decisions that are in the best interest of their company’s shareholders, including the Clients. While receiving compensation for providing Services to Portfolio Companies would pose an actual or perceived conflict of

interest, the Investment Manager believes that the potential benefit to the company’s shareholders, including the Clients, derived from the Investment Manager’s efforts far outweigh the potential drawbacks associates with such conflicts. As part of its fiduciary duty, the Investment Manager has adopted policies and procedures to address and mitigate such conflicts. As a result of the foregoing, the Adviser and the Affiliated Parties may have conflicts of interest in allocating their time and activity between Clients and other entities, in allocating investments among Clients and other entities and in effecting transactions for the Clients and other entities, including ones in which the Adviser and the Affiliated Parties may have a greater financial interest. In addition, purchase and sale transactions (including swaps) may, to the extent not otherwise prohibited by applicable law, be effected between the Clients and the other entities or accounts subject to the following guidelines: (i) such transactions shall be effected for cash consideration at the current market price of the particular securities, and (ii) no extraordinary brokerage commissions or fees (i.e., except for customary transfer fees or commissions) or other remuneration shall be paid in connection with any such transaction. Business and Market Disruptions. Both the operation of the Clients and the markets and investments in which the Clients invest are subject to disruptions due to national or global health emergencies, natural disasters such as floods, earthquakes, and other extreme weather conditions, and man-made catastrophes such as acts of terrorism and sabotage, and other extreme circumstances that are out of the control of the Clients, such as power outages or failures, which cause Client prices of investments to behave erratically and to move in non-historical directions. Such disruptions may close markets or the Adviser’s access to such markets, causing substantial losses to a Client. Counterparties of the Clients are also susceptible to business disruptions which may cause substantial losses to the Clients as well. Enhanced Scrutiny and Potential Regulation of Private Investment Funds. A Client’s ability to achieve its investment objectives, as well as the ability of a Client to conduct its operations, is based on laws and regulations that are subject to change through legislative, judicial or administrative action. Enhanced government scrutiny or regulation could have an adverse impact on the Clients’ operations or its ability to achieve its investment objectives. The combination of scrutiny of private equity firms (along with other alternative asset managers), and their investments, by various politicians, regulators and market commentators, and the public perception that certain alternative asset managers, including private equity firms, contributed to downturns in the U.S. and global financial markets, may complicate or prevent the Clients’ efforts to consummate investments, both in general and relative to competing bidders outside of the alternative asset space. As a result, the Pura Vida Funds may invest in fewer transactions or incur greater expenses or delays in completing investments. Additionally, the SEC has indicated that it intends to seek to enact changes to numerous areas of law and regulations that would impact the business of the Adviser and the Clients. In particular, the SEC has signaled an increased emphasis on investment adviser and private fund regulation and has proposed a number of new rules that, if adopted, would impose significant changes on private fund advisers and their management of private funds, and the SEC is expected to propose additional changes in the future. Any such changes are expected to materially impact the Adviser and its affiliates, the Fund and/or its investments, as well as increasing their expenses. Significant time and resources may be required to comply with new regulations, which potentially will detract from the time and resources dedicated to the Fund.

The Adviser, in the course of its investment management and other activities, may come into possession of confidential or material nonpublic information about issuers of securities, including issuers in which the Adviser or its related persons have invested or seek to invest on behalf of a Client. The Adviser is prohibited from improperly disclosing or using such information for its own benefit or for the benefit of any other person, including the Clients. The Adviser maintains written policies and procedures reasonably designed to prohibit the communication of such information to persons who do not have a legitimate need to know such information and to otherwise ensure that the Adviser is acting in compliance with applicable law. In certain circumstances, the Adviser may possess certain confidential or material nonpublic information that, if disclosed, might be material to a decision to buy, sell, or hold a security. The Adviser and its personnel are prohibited from communicating such information with respect to the Clients or using such information for the Clients’ benefit. To the extent that the Adviser or its related persons invest in the same securities that the Adviser or a related person recommends to a Client, such practices present a conflict where, the Adviser or its related person is in a position to trade in a manner that could adversely affect the Clients. In addition to affecting the Adviser’s or its related person’s objectivity, these practices by the Adviser or its related persons may also harm the Clients by adversely affecting the price at which the Clients’ trades are executed. The Adviser has adopted the following procedures in an effort to minimize such conflicts: the Adviser requires its related persons to pre-clear certain transactions in their personal accounts with the Adviser’s chief compliance officer (the “Chief Compliance Officer”) or her delegate, who may deny permission to execute the transaction if such transaction will have any adverse economic impact on a Client. In addition, the Code prohibits the Adviser or its related persons from executing personal securities transactions of any kind in any securities on a restricted securities list maintained by the Chief Compliance Officer. All related persons to the Adviser are also required to provide quarterly certifications of such transactions. Trading in employee accounts will be reviewed by the Chief Compliance Officer or her delegate and compared with transactions for the client accounts and reviewed against the restricted securities list. To the extent the Adviser buys or sells securities for a Client, at or about the same time that the Adviser or a related person buys or sells the same securities for its own account the Adviser and the related person, if applicable, will do so in accordance with the procedures described above in order to minimize the conflicts stemming from situations where the contemporaneous trading would result in an economic benefit for the Adviser or its related person to the detriment of the client.

It is not the Adviser’s practice to negotiate “execution only” commission rates, thus the Clients may be deemed to be paying for research, brokerage, or other services provided by a broker-dealer which are included in the commission rate. The Adviser receives research or brokerage services from a broker-dealer and/or a third party in connection with Client securities transactions. This is known as a “soft dollar” relationship. The Adviser limits the use of “soft dollars” to obtain services that constitute research and brokerage within the meaning of Section 28I of the Securities Exchange Act of 1934. Research services within Section 28(e) may include, but are not limited to, research reports (including market research); certain financial newsletters and trade journals; software providing analysis of securities portfolios; corporate governance research and rating services; attendance at certain seminars and conferences; discussions with research analysts; meetings with corporate executives; consultants’ advice on portfolio strategy; data services (including services providing market data, company financial data and economic data); advice from brokers on order execution; and certain proxy services. Brokerage services within Section 28(e) may include, but are not limited to, and services related to the execution, clearing and settlement of securities transactions and functions incidental thereto (i.e., connectivity services between and Adviser and a broker-dealer and other relevant parties such as custodians); trading software operated by a broker-dealer to route orders; software that provides trade analytics and trading strategies; software used to transmit orders; clearance and settlement in connection with a trade; electronic communication of allocation instructions; routing settlement instructions; post trade matching of trade information; and services required to the SEC or a self-regulatory organization such as comparison services, electronic confirms or trade affirmations. When the Adviser uses Client brokerage commissions (or markups or markdowns) to obtain research or other products or services, the Adviser receives a benefit because the Adviser does not have to produce or pay for the research, products or services. The Adviser may have an incentive to select or recommend a broker-dealer based on the Adviser’s interest in receiving the research or other products or services, rather than on the Clients’ interest in receiving most favorable execution. The Adviser may cause Clients to pay commissions (or markups or markdowns) higher than those charged by other broker-dealers in return for soft dollar benefits (known as paying-up). In the event that Adviser uses soft dollar benefits, the Adviser will use such benefits to service all Client accounts rather than only those accounts that paid for the benefits. At least annually, selected supervised persons of the Adviser will meet to review the execution performance of its brokers. The review of brokers will consist of various factors, including, as applicable, the factors set forth above, and any other factors that the reviewers deem necessary for the adviser to make a reasonable decision about its best execution determinations. During the last fiscal year, there were no directed client transactions to a particular broker-dealer in return for client referrals. The Adviser does not permit a Client to direct the Adviser to execute transactions through a specified broker-dealer except, if agreed to in the relevant investment management agreement. Aggregation of Orders: The Adviser may aggregate purchase and sale orders of investments held by a Client’s account with similar orders being made simultaneously for other Funds or accounts if, in the Adviser’s reasonable judgment, such aggregation is reasonably likely to result in an overall economic

benefit to such Client based on an evaluation that the Client will be benefited by relatively better purchase or sale prices, lower commission expenses or beneficial timing of transactions, or a combination of these and other factors. In many instances, the purchase or sale of investments for a Client’s account will be effected simultaneously with the purchase or sale of like investments for other accounts or entities. Such transactions may be made at slightly different prices, due to the volume of investments purchased or sold. In such event, the average price of all investments purchased or sold in such transactions may be determined, at the Adviser’s sole discretion, and the Client’s account may be charged or credited, as the case may be, with the average transaction price. Allocation of Trades: The Adviser may at times determine that certain investments will be suitable for acquisition by a Pura Vida Fund and by other accounts managed by the Adviser, possibly including the Adviser’s own accounts or accounts of an affiliate. If that occurs, and the Adviser is not able to acquire the desired aggregate amount of such securities on terms and conditions which the Adviser deems advisable, the Adviser will endeavor in good faith to allocate the limited amount of such securities acquired among the various accounts for which the Adviser considers them to be suitable. The Adviser may make such allocations among the accounts in any manner which it considers to be fair under the circumstances, including but not limited to allocations based on relative account sizes, the degree of risk involved in the securities acquired, and the extent to which a position in such securities is consistent with the investment policies and strategies of the various accounts involved. Additionally, there may be times where a Client has a prior investment or commitment to a company which then has a public or secondary offering. In this case, such Client may get a larger allocation to the new issue or secondary offering as a result of its prior relationship with the company.

The Adviser currently uses a broker-dealer, and may in the future use, other broker-dealers, placement agents, and other persons to refer Clients or investors and pay a marketing fee or commission in connection with such activities, including ongoing payments, at the Adviser’s own expense. In certain cases, the Adviser reserves the right to deduct a percentage of the amount invested by a Client to pay sales fees or charges, on a fully-disclosed basis, to a broker-dealer, placement agent, or other person based upon the investment of the Fund or investor introduced to the Adviser by such broker-dealer, placement agent, or other person. Any such sales fees or charges shall be assessed against the referred Fund or investor and shall reduce the amount actually invested by the Fund or investor with the Adviser.

The Adviser is required to maintain the funds and securities (except for securities that meet the privately offered securities exemption in the Custody Rule) over which it has custody with a “qualified custodian.” Qualified custodians include banks, broker-dealers, FCM and certain foreign financial institutions. Currently, the Adviser has custody over certain Funds’ assets. Rule 206(4)-2 generally imposes on advisers with custody of clients’ funds or securities certain requirements concerning reports to such clients (including underlying investors in certain circumstances) and surprise examinations relating to such clients’ funds or securities. However, The Adviser need not comply with such requirements with respect to pooled investment vehicles if the pooled investment vehicle: (i) is audited at least annually by an independent public accountant, and (ii) distributes its audited financial statements prepared in accordance with generally accepted accounting principles to the client, or, in certain circumstances, all limited partners, members or other beneficial owners, within 120 days (180 days in the case of a fund-of-fund adviser) of its fiscal year end. The Adviser intends to rely upon this exemption from the Rule 206(4)-2 reporting and examination requirements for the Pura Vida Funds.

Because of the difference in the Clients’ respective investment objectives and strategies, risk tolerances, tax statuses, and other criteria, there may be differences amongst the Clients in invested positions and securities held. The Adviser may consider the following factors, among others, in allocating securities among the Clients: (i) each Client’s investment objective and strategy; (ii) each Client’s risk profile; (iii) tax status and restrictions placed on the Client’s portfolio by the Client or by applicable law; (iv) size of the Client; (v) nature and liquidity of the security to be allocated; (vi) size of available position; (vii) current market conditions; and (viii) account liquidity, account requirements for liquidity and timing of cash flows. Although it is the Adviser’s policy to allocate investment opportunities to an eligible Client on a pro rata basis (based on assets under management), these factors may lead the Adviser to allocate securities to the Clients in varying amounts.